高雄醫學大學圖書館 |

Quantitative structure-activity relationships in drug design, predictive toxicology, and risk assessment

Record Type:	Language materials, printed : monographic
Secondary Intellectual Responsibility:	RoyKunal, 1971-
Secondary Intellectual Responsibility:	IGI Global
Description:	PDFs (703 pages)illustrations. :
Subject:	Risk Assessment. -
Subject:	Drug-Related Side Effects and Adverse Reactions. -
Subject:	Drug Antagonism. -
Subject:	Quantitative Structure-Activity Relationship. -
Subject:	Drug Design. -
Subject:	Toxicology. -
Subject:	QSAR (Biochemistry) -
Subject:	Drugs - Design. -
Subject:	CORAL for QSAR/QSPR studies
Subject:	Environmental exposure assessment
Subject:	Lead optimization of potential drug candidates
Subject:	Novel descriptors in QSAR
Subject:	QSAR for antioxidants
Subject:	Toxicity of nanomaterials
Online resource:	http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-4666-8136-1
Notes:	Content Type: text
Summary:	"This book discusses recent advancements in the field of QSARs with special reference to their application in drug development, predictive toxicology, and chemical risk analysis"--Provided by publisher.
ISBN:	9781466681378
Content Note:	An introduction to the basic concepts in QSAR-aided drug design / Maryam Hamzeh-Mivehroud, Babak Sokouti, Siavoush Dastmalchi The "ETA" indices in QSAR/QSPR/QSTR research / Kunal Roy, Rudra Narayan Das Evolution of multivariate image analysis in QSAR: the case for a neglected disease / Matheus P. Freitas, Mariene H. Duarte Quantitative structure-activity/property/toxicity relationships through conceptual density functional theory-based reactivity descriptors / Sudip Pan, Ashutosh Gupta, Venkatesan Subramanian, Pratim K. Chattaraj Importance of applicability domain of QSAR models / Kunal Roy, Supratik Kar QSAR of antioxidants / Omar Deeb, Mohammad Goodarzi QSAR studies on bacterial efflux pump inhibitors / Khac-Minh Thai [and 4 others] Integrated in silico methods for the design and optimization of novel drug candidates: a case study on fluoroquinolones mycobacterium tuberculosis DNA gyrase inhibitors / Nikola Minovski, Marjana Novic Computational approaches for the discovery of novel hepatitis C virus NS3/4A and NS5B inhibitors / Khac-Minh Thai [and 5 others] QSAR models towards cholinesterase inhibitors for the treatment of Alzheimer's disease / C. Gopi Mohan, Shikhar Gupta Ligand- and structure-based drug design of non-steroidal aromatase inhibitors (NSAIs) in breast cancer / Tarun Jha, Nilanajn Adhikari, Amit Kumar Halder, Achintya Saha Computational techniques application in environmental exposure assessment / Karolina Jagiello, Tomasz Puzyn QSAR-based studies of nanomaterials in the environment / Valeria V. Kleandrova, Feng Luan, Alejandro Speck-Planche, M. Natalia D. S. Cordeiro Quantitative nanostructure-activity relationship models for the risk assessment of nanomaterials / Eleni Vrontaki, Thomas Mavromoustakos, Georgia Melagraki, Antreas Afantitis QSPR/QSAR analyses by means of the CORAL software: results, challenges, perspectives / Andrey A. Toropov [and 13 others].

Quantitative structure-activity relationships in drug design, predictive toxicology, and risk assessment
Quantitative structure-activity relationships in drug design, predictive toxicology, and risk assessment / Kunal Roy, editor. - PDFs (703 pages) ; illustrations..
An introduction to the basic concepts in QSAR-aided drug design / Maryam Hamzeh-Mivehroud, Babak Sokouti, Siavoush Dastmalchi.
Content Type: textMedia type: electronicCarrier type: online resourceRestricted to subscribers or individual electronic text purchasers..
Includes bibliographical references..
ISBN 9781466681378ISBN 9781466681361
Risk Assessment.Drug-Related Side Effects and Adverse Reactions.Drug Antagonism.Quantitative Structure-Activity Relationship.Drug Design.Toxicology.QSAR (Biochemistry)Drugs -- Design.
CORAL for QSAR/QSPR studiesEnvironmental exposure assessmentLead optimization of potential drug candidatesNovel descriptors in QSARQSAR for antioxidantsToxicity of nanomaterials

Roy, Kunal

Quantitative structure-activity relationships in drug design, predictive toxicology, and risk assessment
LDR:03762nam a2200445 450 001 288682
005 20150317212022.0
009 a(CaBNVSL)gtp00562234
009 a(OCoLC)905111337
009 00000251
010 1 $a 9781466681378 $b ebook
010 1 $a 9781466681361
012 0 $a 10.4018/978-1-4666-8136-1
020 $b 2015000076
100 $a 20151127d2015 y0engy50 b
102 $a us
105 $a a a 000yy
200 1 $a Quantitative structure-activity relationships in drug design, predictive toxicology, and risk assessment $f Kunal Roy, editor.
215 1 $a PDFs (703 pages) $c illustrations.
300 $a Content Type: text
300 $a Media type: electronic
300 $a Carrier type: online resource
300 $a Restricted to subscribers or individual electronic text purchasers.
301 $a 10.4018/978-1-4666-8136-1
310 $a Also available in print.
320 $a Includes bibliographical references.
327 1 $a An introduction to the basic concepts in QSAR-aided drug design / Maryam Hamzeh-Mivehroud, Babak Sokouti, Siavoush Dastmalchi $a The "ETA" indices in QSAR/QSPR/QSTR research / Kunal Roy, Rudra Narayan Das $a Evolution of multivariate image analysis in QSAR: the case for a neglected disease / Matheus P. Freitas, Mariene H. Duarte $a Quantitative structure-activity/property/toxicity relationships through conceptual density functional theory-based reactivity descriptors / Sudip Pan, Ashutosh Gupta, Venkatesan Subramanian, Pratim K. Chattaraj $a Importance of applicability domain of QSAR models / Kunal Roy, Supratik Kar $a QSAR of antioxidants / Omar Deeb, Mohammad Goodarzi $a QSAR studies on bacterial efflux pump inhibitors / Khac-Minh Thai [and 4 others] $a Integrated in silico methods for the design and optimization of novel drug candidates: a case study on fluoroquinolones $a mycobacterium tuberculosis DNA gyrase inhibitors / Nikola Minovski, Marjana Novic $a Computational approaches for the discovery of novel hepatitis C virus NS3/4A and NS5B inhibitors / Khac-Minh Thai [and 5 others] $a QSAR models towards cholinesterase inhibitors for the treatment of Alzheimer's disease / C. Gopi Mohan, Shikhar Gupta $a Ligand- and structure-based drug design of non-steroidal aromatase inhibitors (NSAIs) in breast cancer / Tarun Jha, Nilanajn Adhikari, Amit Kumar Halder, Achintya Saha $a Computational techniques application in environmental exposure assessment / Karolina Jagiello, Tomasz Puzyn $a QSAR-based studies of nanomaterials in the environment / Valeria V. Kleandrova, Feng Luan, Alejandro Speck-Planche, M. Natalia D. S. Cordeiro $a Quantitative nanostructure-activity relationship models for the risk assessment of nanomaterials / Eleni Vrontaki, Thomas Mavromoustakos, Georgia Melagraki, Antreas Afantitis $a QSPR/QSAR analyses by means of the CORAL software: results, challenges, perspectives / Andrey A. Toropov [and 13 others].
330 $a "This book discusses recent advancements in the field of QSARs with special reference to their application in drug development, predictive toxicology, and chemical risk analysis"--Provided by publisher.
337 $a Mode of access: World Wide Web.
452 1 $1 001(DLC)2015000076
452 1 $1 300 $a Print version: $1 001(DLC) 2015000076 $1 0101 $a 1466681365; 9781466681361
606 $a Risk Assessment. $2 mesh $3 385183
606 $a Drug-Related Side Effects and Adverse Reactions. $2 mesh $3 385182
606 $a Drug Antagonism. $2 mesh $3 385181
606 $a Quantitative Structure-Activity Relationship. $2 mesh $3 385180
606 $a Drug Design. $2 mesh $3 385179
606 $a Toxicology. $2 lc $3 355030
606 $a QSAR (Biochemistry) $2 lc $3 385178
606 $a Drugs $x Design. $2 lc $3 385177
610 1 $a CORAL for QSAR/QSPR studies
610 1 $a Environmental exposure assessment
610 1 $a Lead optimization of potential drug candidates
610 1 $a Novel descriptors in QSAR
610 1 $a QSAR for antioxidants
610 1 $a Toxicity of nanomaterials
676 $a 615.1/9 $v 23
680 $a RS420 $b .Q36 2015e
686 $a QV 745 $b Q16 2015e
702 1 $a Roy $b Kunal $f 1971- $4 editor. $3 385176
712 0 2 $a IGI Global $4 publisher. $3 384552
856 7 $2 http $3 Chapter PDFs via platform $u http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-4666-8136-1